Couldn't be happier to be back from #ASNC2026 in Las Vegas with big achievements. It was a full week, three presentations on stage, two papers out, and some news I'm proud to share below:
1) 🗣️Oral presentation: "Steal Phenomena as a Marker of Complete Occlusion in Patients Undergoing ⁸²Rb PET MPI"
2) 🗣️Oral presentation: "7-Minute Acquisition Protocol for [¹⁸F]Flurpiridaz PET Myocardial Perfusion Imaging: A Feasible Alternative to the Standard Protocol"
3) 🫀 Case presentation: "Improvement in Myocardial Flow Reserve Across Treated and Untreated Territories After PCI: Insights From Serial PET"
4) 🏆I've been selected for the ASNC Future Leaders Program. Honored to be included, and grateful to the people who've supported me along the way.
5) 🎤 My mentor, Mouaz Al-Mallah, MD, MSc, FACC, delivered the prestigious Mario Verani Memorial Lecture, a proud moment to see his work recognized on that stage.
6) 🌟 As a team, we delivered 14 presentations and came away with 5 awards. Incredibly proud of this group.
- On the SMuRF front: For decades we've built cardiovascular risk around the standard modifiable risk factors (SMuRFs): hypertension, diabetes, dyslipidemia, and smoking. Yet a growing share of patients develop coronary disease, and events, without a single one of them, and their outcomes aren't always better for it I am glad with the recent publications of my two SMuRF papers in JACC and EHJ.
JACC: Advances: "Prognostic Impact of CCTA According to Standard Cardiovascular Modifiable Risk Factors" how the prognostic value of coronary CT angiography tracks with a patient's SMuRF profile. https://t.co/rRm52QILEY
European Heart Journal: Cardiovascular Imaging: "Incremental Prognostic Value of Standard Modifiable Risk Factor Burden Across SPECT Myocardial Perfusion Categories a study of 38 917 patients" SMuRF burden added prognostic information across perfusion categories. https://t.co/3iC6xy0RYY
Thank you to my mentors Dr. Mouaz Al-Mallah MD MSc FACC, Dr. Mahmoud Al Rifai and my co-authors and colleagues Maria Alwan Ahmad El Yaman Ibrahim Hassan Patrick Sarkis. This is a team effort, always. @MyASNC@HMethodistCV@MethodistHosp@almallahmo@MariaAlwan_@ahmadyaman2000@IbrahimHassanMD@SarkisPatrick@MalekNayfeh #NuclearCardiology #CardiacImaging #CardiacPET #CVImaging #Cardiology #SMuRF #CardioTwitter #HoustonMethodist
🎉ASNC is excited to announce that Mouaz H. Al-Mallah, MD, MSc, MASNC, will deliver the Mario S. Verani Memorial Lecture at #ASNC2026.
His lecture, “From Perfusion to Precision: Charting the Future of Nuclear Cardiology in a Multimodality World,” will examine the evolving and essential role of nuclear cardiology in today’s increasingly multimodality-focused cardiovascular imaging landscape.
👉 https://t.co/dk2enUGgBp
#ACC26
Attending & presenting our original research at my first in-person ACC was an early 2026 win.
Incredibly grateful to our mentor @almallahmo and all @Almallah_Labs teammates
@HMethodistCV
Extremely grateful to share that I matched at @MethodistHosp for Internal Medicine training.
Truly thankful to my incredible mentor @almallahmo for his guidance and unwavering support, and to the entire Houston Methodist family for their trust and support. This wouldn’t have been possible without Dr @WilliamZoghbi@HeartToProve @ mahmoudalrifai
Excited to continue learning and growing with the Methodist community!
#Match2026
Great case presentation by our research fellow @MariaAlwan_ 👏
Rb-82 PET showed normal perfusion, but F-18 flurpiridaz PET unmasked LAD territory ischemia ; highlighting the superior resolution and diagnostic sensitivity of F-18 imaging. @MyASNC
Honored to attend my first #ACC2026 conference with a moderated poster on MFR & secondary prevention
🚀 Proud to be part of an exceptionally productive team
🙏 Grateful to my mentors for their continuous guidance and support
@HMethodistCV@ACCinTouch
Houston Methodist showing up strong at #ASNC 🙌
And a special cameo from a former Methodist legend in the front 😄
Great to see familiar faces and our fellows doing amazing work!
@DeBakeyCVedu@MohakGuptaMD@MariaAlwan_@almallahmo
Wrapping up Day 2 with a series of very interesting case-based discussions 🫀✨
Highlighting the role of:
• PET for viability in ischemic cardiomyopathy
• PET FDG in non-ischemic cardiomyopathy
• PET in ANOCA
• PET for transplant vasculopathy
Incredible insights from all presenters and panelists!
@AabuzaidDr@m_alfawara@MyASNC #CVNuc #ThinkPET
Great talk by Dr. Aljizeeri on the incorporation of MBF into routine practice and its impact on patient outcomes 🫀
Key conclusions:
🔹 MBF & MFR are robust tools for evaluating chest pain and help explain symptoms in patients with or without obstructive CAD
🔹 MFR provides prognostic value across the full spectrum of cardiovascular disease
🔹 Should be integrated into clinical decision-making when evaluating patients with chest pain
@MyASNC #CVNuc #CVD #ThinkPET
Starting Day 2 of Nuclear Cardiology Now: Middle East with an exciting session by Dr. @PanithayaC on ¹⁸F Flurpiridaz PET MPI 🫀✨
Key highlights:
🔹 Superior image quality: high spatial resolution, high count statistics & excellent contrast resolution
🔹 Residual activity subtraction avoids flow overestimation & restores defect severity
🔹 Adoption barriers: cost, infrastructure, training needs & reimbursement limitations
🔹 Pathways forward: regional distribution, standardized protocols, expanded training & equity-focused implementation
Exciting momentum for the future of ¹⁸F PET MPI!
@MyASNC #CVNuc #ThinkPET #CVD